Lovastatin - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for lovastatin and what is the scope of patent protection?
Lovastatin
is the generic ingredient in three branded drugs marketed by Covis, Actavis Elizabeth, Aurobindo Pharma Usa, Carlsbad, Chartwell Rx, Corepharma, Epic Pharma Llc, Lupin, Sun Pharm Industries, Teva, and Merck, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.There are thirty-three drug master file entries for lovastatin. Twenty-three suppliers are listed for this compound.
Summary for lovastatin
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 11 |
NDAs: | 12 |
Drug Master File Entries: | 33 |
Finished Product Suppliers / Packagers: | 23 |
Raw Ingredient (Bulk) Api Vendors: | 124 |
Clinical Trials: | 76 |
Patent Applications: | 7,114 |
Drug Prices: | Drug price trends for lovastatin |
Drug Sales Revenues: | Drug sales revenues for lovastatin |
What excipients (inactive ingredients) are in lovastatin? | lovastatin excipients list |
DailyMed Link: | lovastatin at DailyMed |
Recent Clinical Trials for lovastatin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | N/A |
Heart Health Research Center | Phase 4 |
AstraZeneca | Phase 4 |
Pharmacology for lovastatin
Drug Class | HMG-CoA Reductase Inhibitor |
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for lovastatin
Anatomical Therapeutic Chemical (ATC) Classes for lovastatin
US Patents and Regulatory Information for lovastatin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Elizabeth | LOVASTATIN | lovastatin | TABLET;ORAL | 075828-002 | Dec 17, 2001 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Aurobindo Pharma Usa | LOVASTATIN | lovastatin | TABLET;ORAL | 075935-003 | Dec 17, 2001 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Chartwell Rx | LOVASTATIN | lovastatin | TABLET;ORAL | 075300-003 | Dec 17, 2001 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Teva | LOVASTATIN | lovastatin | TABLET;ORAL | 075551-002 | Dec 17, 2001 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lovastatin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | ⤷ Subscribe | ⤷ Subscribe |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | ⤷ Subscribe | ⤷ Subscribe |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | ⤷ Subscribe | ⤷ Subscribe |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Lovastatin Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.